Back to Search
Start Over
Vacuna tetravalente de influenza en los programas nacionales de inmunización para los países de América Latina
- Source :
- Universidad Peruana de Ciencias Aplicadas (UPC), Repositorio Academico-UPC, UPC-Institucional, Universidad Peruana de Ciencias Aplicadas, instacron:UPC, Enfermedades Infecciosas y Microbiologia
- Publication Year :
- 2020
- Publisher :
- Zenodo, 2020.
-
Abstract
- Since 2012-2013 influenza season, World Health Organization (who) recommends the formulation of tetravalent vaccines. Globally, many countries already use tetravalent vaccines in their national immunization programs, while in Latin America only a small number. Two Influenza b lineages co-circulate, their epidemiological behavior is unpredictable. On average they represent 22.6% of influenza cases and more than 50% in predominant seasons. The lack of concordance between recommended and circulating strains was 25 and 32% in the 2010-2017 and 2000-2013 seasons, respectively. There are no clinical differences between influenza A and B. It occurs more frequently from five to 19 years of age. Influenza b has a higher proportion of attributable deaths than influenza a (1.1 vs. 0.4%), or 2.65 (95% ci 1.18-5.94). A greater number of hospitalizations when the strains mismatch (46.3 vs. 28.5%; p
Details
- Language :
- Spanish; Castilian
- Database :
- OpenAIRE
- Journal :
- Universidad Peruana de Ciencias Aplicadas (UPC), Repositorio Academico-UPC, UPC-Institucional, Universidad Peruana de Ciencias Aplicadas, instacron:UPC, Enfermedades Infecciosas y Microbiologia
- Accession number :
- edsair.doi.dedup.....3c36dbd17d6c1ba51087fb3fe37d19f6
- Full Text :
- https://doi.org/10.5281/zenodo.6570917